IDH2 and astrocytoma (excluding glioblastoma): The diagnosis was in favor of astrocytoma IDH mutant (IDH1 R132H positive, ATRX mutation, KI67-MIB1 70%, MGMT promoter methylation 55.55%), WHO grade 4.